SEC Company Response from IMMUNIC, INC. (IMUX) (CIK 0001280776) (IMUX) — Apr 14, 2014
IMMUNIC, INC. (IMUX) (CIK 0001280776)
Date: April 14, 2014 · CIK: 0001280776 · Accession: 0001193125-14-142338
AI Filing Summary & Sentiment
File numbers found in text: 333-191711
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
April 14, 2014
VIA ELECTRONIC SUBMISSION
Securities and Exchange
Commission
Mail Stop 3561
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attn:
Jeffrey P. Riedler, Assistant Director
Bryan
J. Pitko, Staff Attorney
Re:
Vital Therapies, Inc.
Registration Statement
Filed on Form S-1
Registration No. 333-191711
Ladies and Gentlemen:
Pursuant to Rule 460 under the
Securities Act of 1933, we wish to advise you that we have distributed approximately 2,684 copies of the Preliminary Prospectus issued April 7, 2014 through the date hereof, to underwriters, dealers, institutions and others.
We have been informed by the participating underwriters that they will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934,
as amended.
We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be
accelerated to 4:00 p.m. Eastern Time, on Wednesday, April 16, 2014 or as soon thereafter as practicable.
[signature page
follows]
Very truly yours,
MERRILL LYNCH, PIERCE, FENNER & SMITH
INCORPORATED
CREDIT SUISSE SECURITIES (USA) LLC
As representatives of the
several Underwriters
By:
MERRILL LYNCH, PIERCE, FENNER & SMITH
INCORPORATED
By:
/s/ Michele A.H. Allong
Name: Michele A.H. Allong
Title: Authorized Signatory
By: CREDIT SUISSE SECURITIES (USA) LLC
By:
/s/ Charles Newton
Name: Charles Newton
Title: Managing Director
[SIGNATURE PAGE TO
ACCELERATION REQUEST OF THE UNDERWRITERS]